Altered hepatic metabolism of fatty acids in rats fed a hypolipidaemic drug, fenofibrate.
The aim of this study was to examine the effects of dietary fenofibrate (0.05% in the diet) on ketone body production and lipid secretion in isolated perfused rat liver. Feeding with fenofibrate for 7-9 days caused an increased liver weight. Ketone body production was significantly greater in the livers perfused with oleic acid than in those perfused without fatty acid, with the elevation of the ratio of beta-hydroxybutyrate:acetoacetate indicating an increased redox potential in mitochondrial compartments by exogenous fatty acid. On the other hand, fenofibrate feeding caused a further stimulation of ketone body production from both endogenous and exogenous fatty acid substrates, respectively, with a decreased ratio of beta-hydroxybutyrate:acetoacetate as compared to respective control livers, indicating a decreased redox potential. Hepatic secretion of triglyceride, but not of cholesterol, was decreased markedly in the fenofibrate-fed rats, especially when oleate was provided, suggesting an inverse relationship between rates of ketogenesis and triglyceride secretion. These results suggest that the altered hepatic metabolism of long-chain fatty acids between oxidation and esterification caused by fenofibrate may thus be a factor responsible for the decreased secretion of triglyceride, hence leading to hypotriglyceridaemia in vivo.
Yamamoto
K
K
Department of Internal Medicine, Saga Medical University School of Medicine, Japan.
Fukuda
N
N
Zhang
L
L
Sakai
T
T
D000090:Acetoacetates / Q000378:metabolism; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002784:Cholesterol / Q000378:metabolism; D004032:Diet; D005227:Fatty Acids / Q000378:metabolism*; D011345:Fenofibrate / Q000008:administration & dosage / Q000494:pharmacology*; D000960:Hypolipidemic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D007657:Ketone Bodies / Q000378:metabolism; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D009929:Organ Size / Q000187:drug effects; D010084:Oxidation-Reduction; D051381:Rats; D017208:Rats, Wistar; D012978:Sodium Oxybate / Q000378:metabolism; D014280:Triglycerides / Q000096:biosynthesis / Q000378:metabolism
D000090:Acetoacetates; D005227:Fatty Acids; D000960:Hypolipidemic Agents; D007657:Ketone Bodies; D014280:Triglycerides; D012978:Sodium Oxybate; D002784:Cholesterol; D011345:Fenofibrate